Epitalon vs Pinealon: evidence, safety and FDA status

PepsRadar · Comparison · AI-assisted, written from the checked facts on each profile · Content updated October 11, 2026 (how dates work) · Not reviewed by a medical professional

The short answer

Both are very short synthetic peptides from the Russian “bioregulator” research tradition, marketed for aging and brain health. Neither is FDA-approved, and the evidence for both is mostly cell and animal work.

Key differences

Epitalon has four amino acids; Pinealon has three.
Epitalon lengthened telomeres in cultured human cells and modestly extended some lifespan measures in flies and certain rodent strains. No study has measured telomeres or lifespan in people given it.
Pinealon: cell studies under oxidative stress reported less free-radical damage and cell death; its human evidence is one small Russian report.
FDA found no clinical data supporting Epitalon’s safety in people, and Pinealon’s human safety is essentially unstudied.

Side by side

Fact	Epitalon	Pinealon
FDA status	Not FDA-approved	Not FDA-approved
What it is	Epitalon, also spelled Epithalon, appears in telomerase and aging discussions. The selected study concerns cultured cells rather than a lifespan trial.	Pinealon is a tripeptide investigated in experimental stress-response biology. The selected publication concerns cells under oxidative stress, rather than a clinical memory or dementia trial.
Human evidence	No human studies in our sources; animal and lab studies only	No human studies in our sources; animal and lab studies only
Human safety data	None. Epitalon is an unapproved synthetic tetrapeptide. FDA found no clinical data supporting its safety in people, and its evidence comes mainly from cell and animal studies.	Very limited. Not an approved drug. Evidence is mostly cell and animal work plus one small Russian human report, so human safety is essentially unstudied.
Boxed warning	No FDA label to carry one	No FDA label to carry one
Serious risks	FDA: possible immune reactions (immunogenicity) from aggregation and peptide impurities in compounded products	None listed
Conditions flagged	None flagged, because there is too little human safety data to assess	None flagged, because there is too little human safety data to assess
Claim check	Unproven: Epitalon lengthens telomeres and extends lifespan.	No claim check yet

Each row comes from the Epitalon and Pinealon profiles, where every fact links to its source. “Conditions flagged” lists the health conditions each profile’s Risks & interactions section mentions.

The human studies

Epitalon

No human studies in our sources. See the Epitalon profile for the animal and lab research.

Pinealon

No human studies in our sources. See the Pinealon profile for the animal and lab research.

Results from different trials are not a head-to-head comparison: the people, preparations, durations and measures differ.

Bottom line

Interesting laboratory leads, not demonstrated anti-aging or memory treatments.

PepsRadar does not give doses or usage instructions, and this page is not medical advice. For a prescription medicine, talk to your prescriber or pharmacist.

Other comparisons: BPC-157 vs TB-500 · Semaglutide vs Tirzepatide · Tirzepatide vs Retatrutide · CJC-1295 vs Ipamorelin · Sermorelin vs Tesamorelin · Selank vs Semax · MOTS-c vs Elamipretide · Ipamorelin vs MK-677 · AOD-9604 vs HGH Fragment 176-191 · Thymosin alpha-1 vs Thymosin beta-4 · Tesamorelin vs CJC-1295 · GHK-Cu vs AHK-Cu

See something wrong on this page? Report a mistake · Corrections